Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Non-Current Deffered Revenue (2020 - 2021)

Terns Pharmaceuticals (TERN) has disclosed Non-Current Deffered Revenue for 2 consecutive years, with $160000.0 as the latest value for Q4 2021.

  • For the quarter ending Q4 2021, Non-Current Deffered Revenue fell 27.27% year-over-year to $160000.0, compared with a TTM value of $160000.0 through Dec 2021, down 27.27%, and an annual FY2021 reading of $160000.0, down 27.27% over the prior year.
  • Non-Current Deffered Revenue was $160000.0 for Q4 2021 at Terns Pharmaceuticals, down from $176000.0 in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $220000.0 in Q4 2020 and bottomed at $160000.0 in Q4 2021.